Ithd.Psx
The company is a chemical manufacturer operating in the commodity chemicals industry, producing and selling a range of chemical products to industrial and commercial customers.
Business. The company is a chemical manufacturer operating in the commodity chemicals industry, producing and selling a range of chemical products to industrial and commercial customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company is a chemical manufacturer operating in the commodity chemicals industry, producing and selling a range of chemical products to industrial and commercial customers.
The company maintains a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing, and a current ratio of 1.05, suggesting limited short-term liquidity cushion. Free cash flow is negative at -$669.2 million, driven by capital expenditures of -$2.37 billion, which exceeds operating cash flow of $986.7 million. Return on equity of 12.62% and return on assets of 6.4% are above the industry median for commodity chemicals, reflecting strong asset utilization and profitability.
Profitability metrics align with the industry's preferred KPIs, with a gross margin of 17.92% (calculated as gross profit of $4.99 billion divided by revenue of $27.86 billion) and an operating margin of 10.23% (calculated as operating income of $2.85 billion divided by revenue of $27.86 billion). These figures suggest the company is efficiently managing production costs and maintaining pricing power in a competitive market.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, indicating potential exposure to regional economic or regulatory shifts. This lack of diversification could amplify the impact of downturns in key markets or supply chain disruptions.
Outlook for the current fiscal year shows a projected revenue increase of 8.5% year-over-year, supported by stable demand in core markets and capacity expansion. For the next fiscal year, revenue is expected to grow by 5.2%, driven by new product launches and market share gains. These projections are consistent with the company's historical revenue growth of 6.3% over the past three years.
Risk factors include medium liquidity risk due to negative free cash flow and a current ratio near 1.0, as well as potential dilution from a $500 million shelf registration filed in Q1 2024. The company has not issued new shares in the past 12 months, and no material dilution events are currently expected.
Recent events include the filing of a 10-K annual report in March 2024, which disclosed plans to expand production capacity in North America by 2026. Additionally, the company announced a strategic partnership with a European chemical distributor in Q2 2024 to access new markets.
- The company demonstrates strong profitability with ROE of 12.62% and ROA of 6.4%, outperforming industry medians.
- Free cash flow is negative due to significant capital expenditures, which may limit near-term shareholder returns.
- Revenue is concentrated in a single segment and geographic region, increasing exposure to market-specific risks.
- Outlook for the next two fiscal years is positive, with revenue growth projections of 8.5% and 5.2%, respectively.
- Liquidity risk is moderate, with a current ratio of 1.05 and negative free cash flow.
- "margin_outlook_rationale": "Operating margin is expected to remain stable due to controlled production costs and pricing discipline in core markets.",
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- ITHD.PSX Market data — financials · 2026-05-28